U.S. Markets closed

Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks

Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks

U.S. stock markets have been exceedingly volatile in 2022. The billionaire brothers Julian and Felix Baker -- co-owners of the biotechnology focused hedge fund Baker Bros. Advisors -- are a prime example. Perhaps most interestingly, the Baker brothers bought large chunks of small-cap healthcare stocks Affimed (NASDAQ: AFMD), Cerus Corporation (NASDAQ: CERS), and Replimune Group (NASDAQ: REPL) in the most recent quarter.